# Self-administered Hyperinsufflation Chest on the Risk of Low Respiratory Infection in Patients With Multiple Sclerosis With Sputum Capacity Deficit

> **NCT04563832** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 84 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** Standardized respiratory management program
- **OTHER:** CoughAssist

## Key facts

- **NCT ID:** NCT04563832
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-25
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04563832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04563832, "Self-administered Hyperinsufflation Chest on the Risk of Low Respiratory Infection in Patients With Multiple Sclerosis With Sputum Capacity Deficit". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT04563832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*